Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder Suppliers & Bulk Manufacturers
Available Forms: Lyophilized Powder (Reconstituted for IV infusion)
Available Strengths: 500 units, 1000 units, and 2500 units
Reference Brands: FEIBA(US)
Category: Blood Disorder
Anti-Inhibitor Coagulant Complex (AICC), like FEIBA, provides concentrated clotting factors, bypassing inhibitors in hemophilia. It restores blood clotting, controls bleeding episodes, and reduces bleeding severity. Benefits include rapid bleeding control, improved hemostasis, and saved lives during severe hemorrhages in patients with inhibitors.
Product Description: Anti-Inhibitor Coagulant Complex (AICC), such as FEIBA, is approved in the US by the FDA and in the EU via EMA for managing bleeding in hemophilia patients with inhibitors. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and manufacturing information, while the EMA ensures compliance with regional safety and quality requirements. For guidance on dossier preparation, regulatory strategies, and market access, visit PharmaTradz. Ensuring regional compliance is essential for the safe, effective, and timely approval of AICC products worldwide, supporting optimal hemophilia patient care.
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder — third party manufacturing & bulk supply
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder is supplied as Lyophilized Powder (Reconstituted for IV infusion) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Anti-Inhibitor Coagulant Complex (Aicc)... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Anagrelide Hydrochloride
Strength:
0.5 mg
Form: Capsules
Reference Brands: Agrylin (USA)
View Details
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View Details
Lusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
